Trial intelligence / Profile preview

Thoracic paravertebral block with levobupivacaine plus sufentanil for postoperative pain

2008-005712-40Phase 3Completed

Sponsor
Policlinico Gemelli
Start
Oct 2008
Modality
Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3 trial of sufentanil and levobupivacaine in postoperative pain, sponsored by Policlinico Gemelli. Primary endpoints: Effectiveness of postoperative pain management and Safety of paravertebral administration of sufentanil. Started Oct 2008; status: completed.

02

Drugs

sufentanillevobupivacaine
03

Conditions

postoperative pain

Beyond the preview

Go deeper on 2008-005712-40.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2008-005712-40.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call